Miriam Braunstein, Ph.D.
Colorado State University
Miriam Braunstein, Ph.D. is a professor in the Microbiology, Immunology, and Pathology Department at Colorado State University. Prior to joining Colorado State, she was a professor of microbiology and immunology at the University of North Carolina School of Medicine. She received her Ph.D. from Princeton University, where she carried out graduate research with Dr. James Broach on the Sir2 protein of Saccharomyces cerevisiae, histone deacetylation and transcriptional silencing.
After completing her degree, Braunstein became a Life Sciences Research Foundation Fellow working at the Albert Einstein College of Medicine with Dr. William Jacobs, Jr. It was during her postdoctoral training that she began studying Mycobacterium tuberculosis, the bacterial pathogen responsible for tuberculosis.
Braunstein's laboratory studies the basic biology and pathogenic mechanisms of mycobacterial pathogens, including M. tuberculosis and nontuberculous mycobacteria. Her research includes mechanistic studies of mycobacterial protein secretion pathways and of secreted effector proteins that promote mycobacterial survival in macrophages. Her laboratory also collaborates on translational projects to develop new therapies for mycobacterial disease, which includes exploring the potential to use bacteriophage as an anti-mycobacterial therapy. Braunstein is the recipient of a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award and a Fellow of the American Academy of Microbiology.
After completing her degree, Braunstein became a Life Sciences Research Foundation Fellow working at the Albert Einstein College of Medicine with Dr. William Jacobs, Jr. It was during her postdoctoral training that she began studying Mycobacterium tuberculosis, the bacterial pathogen responsible for tuberculosis.
Braunstein's laboratory studies the basic biology and pathogenic mechanisms of mycobacterial pathogens, including M. tuberculosis and nontuberculous mycobacteria. Her research includes mechanistic studies of mycobacterial protein secretion pathways and of secreted effector proteins that promote mycobacterial survival in macrophages. Her laboratory also collaborates on translational projects to develop new therapies for mycobacterial disease, which includes exploring the potential to use bacteriophage as an anti-mycobacterial therapy. Braunstein is the recipient of a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award and a Fellow of the American Academy of Microbiology.